References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Maetal(2002)ThiazolidinoneCFTRinhibitoridentifiedbyhigh-throughputscreeningblockscholeratoxin-inducedintestinalfluidsecretion.J.Clin.Invest.1101651PMID:12464670
Taddeietal(2004)AlteredchannelgatingmechanismforCFTRinhibitionbyahigh-affinitythiazolidinoneblocker.FEBSLett.55852PMID:14759515
Yangetal(2008)Small-moleculeCFTRinhibitorsslowcystgrowthinpolycystickidneydisease.J.Am.Soc.Nephrol.191300PMID:18385427
Raffertyetal(2009)RescueoffunctionalF508delcysticfibrosistransmembraneconductanceregulatorbyvasoactiveintestinalpeptideinthehumannasalepithelialcelllineJME/CF15.J.Pharmacol.Exp.Ther.3312PMID:19584307
Kellyetal(2010)CysticfibrosistransmembraneregulatorinhibitorsCFTRinh-172andGlyH-101targetmitochondrialfunctions,independentlyofchloridechannelinhibition.J.Pharmaco.Exp.Ther.33360PMID:
Keywords:CFTRinh172,supplier,Voltage-independent,selective,CFTR,chloride,channel,blockers,Cl-,Channels,CFTRinh172,CFTR,CFTR,TocrisBioscience